British American Tobacco PLC (BTI) Options

Don’t overlook this undervalued synergy!

British American Tobacco already has existing deals with both Charlottes Web Holdings $CWBHF and Organigram Holdings $OGI… There are a few possibilities for how BAT could leverage its partnerships with both companies:

Joint Investment: BAT, Charlottes Web, and Organigram could collaborate on a joint venture or even a merger (depending on regulations) to create a larger cannabis and CBD company. This would require significant planning and navigating potential regulatory hurdles.”

Market Expansion: BATs global reach could be valuable for both Charlottes Web and Organigram. BAT could help them enter new markets where cannabis or CBD products are legal. For example, BAT might leverage its existing distribution channels for these products.

Knowledge Sharing: BAT could act as a bridge between the two companies, facilitating knowledge sharing and best practices in areas like marketing, regulatory compliance, and cultivation techniques.

this is trading cheap Yeah tobacco isn't the hot thing to invest in but it makes money and lots of it

Easy buy here indeed

"British American Tobacco : BAT invests in Charlotte's Web, a leading US producer of hemp extract wellness products":
11/14/2022 | 06:11pm EST
https://www.marketscreener.com/quote/stock/BRITISH-AMERICAN-TOBACCO-4001163/news/British-American-Tobacco-BAT-invests-in-Charlotte-s-Web-a-leading-US-producer-of-hemp-extract-wel-42312972/

"BAT invests in Charlotte’s Web, a leading US producer of hemp extract wellness products":
14 November 2022
https://www.bat.com/group/sites/UK__9D9KCY.nsf/vwPagesWebLive/DOCL6PSP#

FYI...$BTI+$CWBHF...
Effective as of November 14, 2022, we entered into a subscription agreement with BT DE Investments, Inc. a wholly-owned subsidiary of BAT Group (LSE: BATS and NYSE: BTI), providing for the issuance of an approximately $56.8 million convertible debenture (the “Debenture”) is convertible into 19.9% ownership of the Company’s common shares at a conversion price of C$2.00 per common share of the Company on the Toronto Stock Exchange (TSX). The Debenture will accrue interest at an annualized rate of 5% until such time that there is federal regulation permitting the use of CBD as an ingredient in food products and dietary supplements in the United States. Following federal regulation of CBD, the annualized rate of interest shall reduce to 1.5%. The maturity date for the Debenture shall be November 2029. The Subscription Agreement contains customary representations and warranties and covenants. The funds from this Debenture can be used for operating purposes to fund the Company, as approved by the board of directors or in accordance with the Company’s board-approved budget.
https://www.otcmarkets.com/filing/html?id=16201884&guid=Ly_-kFBCz96Iyih

looks like people are being smart and putting there money in these type of stocks low PE and healthy dividend and cigarettes are bought in any economy lol

BTI raising back up up 10% here

“British American Tobacco (BAT), the world’s No. 2 tobacco company, on Wednesday warned of steeper declines in cigarette sales globally mainly due to waning demand in its main U.S. market, sending its shares lower.”

https://www.reuters.com/article/us-brit-am-tobacco-outlook/bat-warns-of-steeper-declines-in-cigarette-sales-shares-slip-idUSKCN1TD0NH

Short here with Brexit uncertainty and bearish parSAR on the inverted technical pincher chart. GL!

https://stockcharts.com/h-sc/ui?s=BTI&p=D&yr=0&mn=7&dy=0&id=p42191071415

Vuse will take over the vaping market. Ready to enter here soon. Juul (aka Phillip Morris) is done for.

BTI SHOULD take over this little known Canadian company ABCANN. Deal or no deal.

Don't miss our Group Scientific and R&D Director, Dr David O'Reilly, as the closing keynote speech at this years #GTNF at 17:40 EST pic.twitter.com/jXuEG3YWgr— BAT Science (@BAT_Sci) September 14, 2017

http://blumartini.com/22nd-century-group-inc-extreme-growth-potential-and-takeover-target-interview-with-the-ceo/

Just because I wrote it and it's a great read. Go register while you're there!

https://www.nytimes.com/reuters/2017/08/31/business/31reuters-brit-am-tobacco-moves.html

BTI and XXII gonna cut a deal? Should find out in less than a month

Agreed. Both XXII and BTI should take off soon

We are going to find out very soon. XXII and BAT could find themselves at the forefront of something amazing in the industry

I would think it's gonna pick up soon here. Both tickers should benefit if things play out

We will find out soon enough and NLT 10.1

Time and time again tobacco shows us the incredible long term potential it has. So long as the government refrains from prohibition people will pay a reasonable tax to buy the smoke they love. MONEY FOR ALL AROUND.

The RAI merge was incredible making this IMO the greatest tobacco conglomerate around.

I LOVE tobacco stocks but especially THIS one.

This will be worth $150+ per share in 5 years easy.

Incredible potential here

XXII AND BTI TOGETHER HAND IN HAND

Well wrong board? Doesn't matter,hopefully research will make a a life changing outcome for all .

??? Is this part of the same research?
http://www.ctvnews.ca/health/canadian-researchers-break-blood-brain-barrier-with-new-ultrasound-treatment-1.2648878

Bioasis board?

Very smart move on the part of both BAT & XXII to sign an agreement to advance the two companies utilizing XXII's proprietary properties. Great things to come for those vested in both. Below from the N/R by both BAT & XXII

“This partnership with British American Tobacco, which sells product in approximately 180 countries, represents 22nd Century’s greatest growth milestone to date and an important step in the development of 22nd Century’s next generation tobacco products. BAT has always been our first choice as a partner,” stated Joseph Pandolfino, 22nd Century’s Founder and Chief Executive Officer.

Gary Nicholson, BAT’s Head of Global Leaf Research, stated that “BAT is excited to be working with 22nd Century in this area of developing technology. This work is part of BAT’s ongoing Research & Development activities relating to tobacco products.”

About 22nd Century Group, Inc.

22nd Century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine and other nicotinic alkaloids (e.g., nornicotine, anatabine and anabasine) in the tobacco plant to be decreased or increased through genetic engineering or plant breeding. 22nd Century owns or is the exclusive licensee of 112 issued patents in 78 countries plus an additional 38 pending patent applications. Goodrich Tobacco Company, LLC and Hercules Pharmaceuticals, LLC are wholly-owned subsidiaries of 22nd Century. Goodrich Tobacco is focused on commercial tobacco products and tobacco harm reduction products in development. Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development.

Why no chatter on this board..... XXII......Deal?